Top Markets
Coin of the day
Nextgen Biomed Ltd Nextgen Biomed Ltd

Nextgen Biomed Ltd

NXGN
Rank in Stocks #37893
Nextgen Biomed Ltd focuses on developing external dermatological treatments for... Nextgen Biomed Ltd focuses on developing external dermatological treatments for psoriasis. The company, which was established in 1990, originally operated under the name Sela Group.Com Ltd. before rebranding as Nextgen Biomed Ltd in February 2010. Its operations are headquartered in Tel Aviv, Israel.
Share Price
$0.14896012
Last synced: 2026-02-16
Market Cap
$1.37M
Change (1 day)
-2.89%
Change (1 year)
-19.65%
Country
IL
Trade Nextgen Biomed Ltd (NXGN)

Category

P/B ratio for Nextgen Biomed Ltd (NXGN)
P/B ratio as of 2026 TTM: 0
According to Nextgen Biomed Ltd latest financial reports and stock price the company's current price-to-book ratio (TTM) is 0. At the end of 2026 the company had a P/B ratio of 0.
P/B ratio history for Nextgen Biomed Ltd from 2026 to 2026
P/B ratio at the end of each year
Year P/B Ratio Change
Not enough data for the provided dates.
P/B ratio for similar companies or competitors
Company P/B Ratio P/B Ratio Difference Country
6.8941 -
US
1.9293 -
FR
- -
JP
1.926 -
US
- -
CH